Glenview's 5.4% stake is a new passive position, but given their activist history in healthcare, monitor for any future conversion to a 13D or public engagement. The filing date (Oct 13) is just after the quarter end, suggesting recent accumulation.
Price Chart
Executive Summary
Glenview Capital Management (Larry Robbins) filed a new SC 13G disclosing a 5.4% passive stake in Surgery Partners, Inc. as of October 6, 2026. The filing confirms no intent to influence control, but Glenview's presence as a notable healthcare-focused hedge fund adds scrutiny. The stake is sizable at 7,023,338 shares, representing a new position for this filer.
Key Financial Metrics
Key Facts
- Glenview Capital Management and Larry Robbins filed a Schedule 13G on October 13, 2026.
- Beneficial ownership: 7,023,338 shares of common stock, representing 5.4% of shares outstanding.
- Shares outstanding as of August 3, 2026: 130,918,260 (per issuer's 10-Q).
- Stake held across Glenview Capital Master Fund, Glenview Offshore Opportunity Master Fund, Glenview Healthcare Master Fund, and two managed accounts.
- Filed under Rule 13d-1(c) — passive intent, no control or influence purpose.
- Glenview is a healthcare-focused hedge fund managed by Larry Robbins.
Financial Impact
5.4% passive stake valued at approximately $X (no price provided in filing).
Risk Factors
- Potential future conversion to activist 13D if Glenview seeks changes.
- No explicit exit plan — stake could be sold without notice.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000905148-26-004453 |
| Document: powerofattorney.htm | 0000905148-26-004453 |
| Document: 0000905148-26-004453-index-headers.html | 0000905148-26-004453 |
| Document: 0000905148-26-004453-index.html | 0000905148-26-004453 |
| Document: 0000905148-26-004453.txt | 0000905148-26-004453 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | DEFA14A | $23.20 | awaiting T+5 | — | $23.36 (+0.69%) |
Oct 26, 2026 1d ago | DEFA14A | $23.32 | awaiting T+5 | — | $23.36 (+0.17%) |
Oct 26, 2026 1d ago | SC 13D/A | $23.25 | awaiting T+5 | — | $23.36 (+0.47%) |
Oct 26, 2026 1d ago | DEFA14A | $23.25 | awaiting T+5 | — | $23.36 (+0.47%) |
Oct 26, 2026 1d ago | 8-K | $23.25 | awaiting T+5 | — | $23.36 (+0.47%) |
Oct 13, 2026 14d ago | SC 13G | $14.83 $15.40 | ▲ +3.84% | ▲ +3.39% | $23.36 (+57.52%) |
Sep 17, 2026 5w ago | 8-K | $13.35 $14.20 | ▲ +6.37% | ▲ +5.77% | $23.36 (+74.98%) |
Sep 17, 2026 5w ago | Press Release | $13.35 $14.20 | ▲ +6.37% | ▲ +5.52% | $23.36 (+74.98%) |
Aug 20, 2026 9w ago | Insider Buy | $14.52 $13.69 | ▼ −5.72% | ▼ −6.19% | $23.36 (+60.88%) |
Aug 10, 2026 11w ago | 8-K | $15.95 $14.36 | ▼ −9.97% | ▼ −9.92% | $23.36 (+46.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers